G. Pajkos et al., The prognostic value of the presence of mutations at the codons 12, 13, 61of K-ras oncogene in colorectal cancer, ANTICANC R, 20(3A), 2000, pp. 1695-1701
The predictive and prognostic value of the c-K-ras mutation is still unequi
vocal despite extensive and intensive studies. Investigation of the occurre
nce of mutations in 88 colorectal cancer patients' specimens using the poly
merase chain reaction (PCR) is reported: age: 61.9 years (27-80), gender: 4
8 male 42 female, Dukes' stages: 43 at B, 35 at C, 10 at D, primary of tumo
ur: 52 colon, 36 rectal adenocarcinoma. Mutation of one of the three ras-co
dons was detectable in the 54 cases, more frequently at the Dukes' stage C
(p < 0.05). The ras-mutation correlated to a more elevated death-rate in th
e Dukes' B and C stages (p < 0.01). Mean survival time and time to progress
ion were significantly longer at the Dukes' stage B if mutation was not det
ected (p < 0.01). The genetic alteration occurred significantly more freque
ntly at tumours of the right-side colon, than the left side (p < 0.02) or r
ectum (p < 0.05). However, in the age group of 41-50 years; it was more sig
nificantly identified in the cases of rectal cancer (p < 0.01). At the age
of 51-60 years mutations were detected in men at a higher rate (p < 0.05).
The mutation of the codon 13 appeared mon frequently in the cases of local
recurrences (p < 0.05). The occurrence of the ras-oncogene is a sign of an
extremely malignant potential of tumour This fact manifested itself in the
time to progression and mean survival time of patients at the same clinical
ol pathological stage. The higher frequency of genetic alterations at the
proximal colon may be the reason for more unfavourable prognosis of the dis
ease localised to this site. Reconstructing the molecular events, the prese
nce of the ras mutation proved to be an important element for prognosis of
the disease and should be a basis of potentially individualised therapeutic
intervention.